Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX.
Department of Surgery, Medical College of Wisconsin, Milwaukee, WI.
JCO Oncol Pract. 2023 Jul;19(7):446-455. doi: 10.1200/OP.22.00578. Epub 2023 Apr 17.
The clinical benefit of preoperative breast magnetic resonance imaging (MRI) for early-stage breast cancer (BC) remains controversial. We examined trends and the associated factors of preoperative breast MRI use.
This study cohort, constructed from Optum Clinformatics database, included women with early-stage BC who had a cancer surgery between March 1, 2008, and December 31, 2020. Preoperative breast MRI was performed between the date of BC diagnosis and index surgery. Multivariable logistic regressions, one for elderly (65 years and older) and the other for non-elderly patients (younger than 65 years), were performed to examine factors associated with the use of preoperative MRI.
Among 92,077 women with early-stage BC, the crude rate of preoperative breast MRI increased from 48% in 2008 to 60% in 2020 for nonelderly and from 27% to 34% for elderly women. For both age groups, non-Hispanic Blacks were less likely (odds ratio [OR]; 95% CI, younger than 65 years: 0.75, 0.70 to 0.81; 65 years and older: 0.77, 0.72 to 0.83) to receive preoperative MRI than non-Hispanic White patients. Across Census divisions, the highest adjusted rate was observed in Mountain division (OR compared with New England; 95% CI, younger than 65 years: 1.45, 1.27 to 1.65; 65 years and older: 2.42, 2.16 to 2.72). Other factors included younger age, fewer comorbidities, family history of BC, axillary node involvement, and neoadjuvant chemotherapy for both age groups.
The use of preoperative breast MRI has steadily increased. Aside from clinical factors, age, race/ethnicity, and geographic location were associated with preoperative MRI use. This information is important for future implementation or deimplementation strategies of preoperative MRI.
术前乳腺磁共振成像(MRI)在早期乳腺癌(BC)中的临床获益仍存在争议。本研究旨在探讨术前乳腺 MRI 应用的趋势及其相关因素。
本研究队列来自 Optum Clinformatics 数据库,纳入了 2008 年 3 月 1 日至 2020 年 12 月 31 日期间接受癌症手术的早期 BC 女性患者。术前乳腺 MRI 检查在 BC 诊断日期和指数手术之间进行。对 65 岁及以上的老年患者和 65 岁以下的非老年患者分别进行多变量逻辑回归分析,以评估与术前 MRI 使用相关的因素。
在 92077 例早期 BC 女性患者中,非老年患者术前乳腺 MRI 的粗率从 2008 年的 48%增加到 2020 年的 60%,老年患者从 27%增加到 34%。对于两个年龄组,非西班牙裔黑人接受术前 MRI 的可能性均低于非西班牙裔白人(比值比[OR];95%置信区间,65 岁以下:0.75,0.70 至 0.81;65 岁及以上:0.77,0.72 至 0.83)。在各个人口普查区中,山区的调整后接受率最高(与新英格兰相比;95%置信区间,65 岁以下:1.45,1.27 至 1.65;65 岁及以上:2.42,2.16 至 2.72)。其他因素包括年龄较小、合并症较少、BC 家族史、腋窝淋巴结受累和新辅助化疗。
术前乳腺 MRI 的使用稳步增加。除了临床因素外,年龄、种族/族裔和地理位置与术前 MRI 的使用相关。这些信息对于未来术前 MRI 的实施或取消策略很重要。